I am a writer and social media marketer with 11+ years of experience. I have a Bachelor's of Journalism & Master's of Science in Medical Science - Biomedical Neuroscience. Email: mollie100yearsco.com
Analysts Predict Slower Rollout but Ultimate Victory for Casgevy in Race with Lyfgenia
It's been nearly four months since the FDA's historic Dec. 8, 2023 dual approvals of Vertex-CRISPR's hashtag#Casgevy and bluebird bio's hashtag#Lyfgenia, the first cell-based hashtag#genetherapies approved for hashtag#sicklecelldisease. How are the rollouts of these expensive treatments going? And which one will emerge as the victor?
Dewey Receives NIH Research Grant to Expand Studies on Mechanisms of Hearing in Mammals
The grant will allow him to expand his research at the USC Caruso Department of Otolaryngology Head and Neck Surgery on the role of outer hair cells in normal hearing.
Recently Laid Off? Contract Work Could Be an Attractive Option
Staffing agencies say contract work is a great way to break into an industry and avoid a resume gap.
Baisong Mei’s Immigrant Journey Through American Biopharma
Baisong Mei is no stranger to leadership roles. At just 15 years old, he was already in medical school leading a group of students 10 years his senior.
How a Promise Sparked Ray CEO Paul Bresge’s Quest to Treat a Blinding Disease
For Paul Bresge, getting into biotech wasn’t fulfilling a career goal. It was fulfilling a promise.
Despite Tough Market, Some Life Science IPOs Find Success
The handful of biotechs that went public in 2023 fared well, providing hope to a cautiously optimistic sector.
Hannah Wastyk’s Path from Academia to Biotech
The Interface Biosciences co-founder said forging the relationships needed to launch a startup can be a challenge for members of underrepresented groups, making confidence and adaptability key.
Ask the Ecz-perts: How to Care for Hypopigmentation
In this edition of Ask the Ecz-perts, we get the lowdown on how people with eczema can care for hypopigmentation, which is light spots of the skin. Our experts talk about causes of the light spots and how you can treat them.
How to Cope with Layoffs and Other Career Setbacks
It’s been a difficult year for biopharma, with many companies doing rounds of layoffs, a parched investment climate for startups and multiple bankruptcies. When these things happen to you, it’s hard not to take them personally or view them as a failure.
Does Pay for Performance Work? It Depends
A study finds that employees are more likely to view pay for performance positively—and rise to the challenge of performing well—when they view their managers as friendly and good at their jobs.
Mirati, Amgen, Lilly and More Race to the Front Line in KRAS-Mutated NSCLC
With Amgen’s Lumakras and Mirati’s Krazati already approved for the second-line treatment of KRAS-mutated non-small cell lung cancer, the longtime competitors—along with newer contenders—are vying to bring the first KRAS inhibitor to the frontline.
A Resident’s Journey Through the USC Caruso Department of Otolaryngology – Head and Neck Surgery
For Ido Badash, MD, the key for medical students to finding success in residency is to choose a place where one can see themselves thriving with plenty of opportunities to reach one’s full potential.
How Companies Use AI to Grade Candidates—and Even Potential Locations
The biopharma industry is moving toward AI to try to determine how well a person would perform in a role, with applications that go beyond recruiting.
New regenerative treatment helps priest find his voice
After spending years trying to recover his voice with his initial surgeon, a specialist, and speech pathologist, his regional laryngologist finally recommended that he come to Keck Medicine of USC to see Dr. Johns in 2021 to try a new regenerative treatment using platelet rich plasma.
First RNA Editing Therapy Nears Clinic as Excitement Mounts
Its reversible nature offers the potential for RNA editing to go beyond rare diseases, eliciting excitement and buy-in from large pharmas like GSK and Eli Lilly.